ARxIUM logo

ARxIUM

ARxIUM, with headquarters in Buffalo Grove, Illinois and Winnipeg, Manitoba, makes pharmacy automation, including the RIVA robot that compounds IV syringes and bags, FastPak medication packagers, and MedSelect dispensing cabinets. Its revenue is an estimated 15 million to 30 million dollars.5,3,4,7

Robotics Reviewed Editorial TeamUpdated November 10, 2026arxium.com

Our take

ARxIUM's robot is RIVA, a fully automated system that prepares hazardous and non-hazardous IV syringes and bags while supporting USP 797 and USP 800 requirements. ARxIUM says RIVA had prepared more than 19 million doses by April 2026.3,4

Around RIVA it sells unit-dose packagers, vial fillers, central fill systems, dispensing cabinets, and inventory software, so it suits hospital and health system pharmacies that want one automation partner. Prices are not published.1,3

Scores by criterion

ARxIUM scores out of 10
Pricing transparency3.0
Product maturity8.0
Deployment evidence7.5
Company durability6.5
Ease of integration7.0
Overall score (average of the five)6.4

Pricing transparency, 3.0: ARxIUM lists no prices and asks buyers to request a consultation or talk to an expert.1

Product maturity, 8.0: ARxIUM says it has worked in pharmacy automation for more than 30 years. RIVA is North American safety listed and CE marked and keeps an electronic audit trail for every dose.2,3

Deployment evidence, 7.5: RIVA passed 19 million doses in April 2026, and in September 2026 Prinses Máxima Centrum in the Netherlands passed one million sterile doses compounded with RIVA.4

Company durability, 6.5: ARxIUM is private and does not publish revenue. GetLatka estimates about 14.1 million dollars a year with 128 employees, and we use an estimated 15 million to 30 million dollars. It achieved HITRUST e1 certification in 2026.7,1

Ease of integration, 7.0: RIVA works with the Codonics Safe Label System to print barcode-verified labels matched to the hospital's drug database, and ARxIUM's inventory platform links to procurement systems.3,1

Each criterion is defined on our methodology page.

Who uses ARxIUM and what it's for

The buyer is a hospital or health system pharmacy that compounds IV syringes and bags in house and wants to cut manual compounding, waste, and outsourcing while meeting USP 797 and 800.3

Buyers should compare it with Equashield, Kiro Grifols, Omnicell, and Loccioni.

RIVA and the wider pharmacy line

RIVA prepares syringes and IV bags in a closed system, which ARxIUM says minimizes discarded doses and packaging, and it helps reduce waste through optimized batch sizes and extended beyond-use dating.3

FastPak Tabletop II, available from October 2026, makes up to 80 barcoded unit-dose packages a minute in a 4.5 square foot footprint. MedSelect Aspire dispensing cabinets and a MedSelect Anesthesia Station launched in December 2025.6,4

Deployments

Prinses Máxima Centrum marked one million sterile doses on RIVA in September 2026 after years of work with ARxIUM.4

ARxIUM works with customers and distributors worldwide from its headquarters in Canada and the United States.2,5

Pricing

ARxIUM does not publish prices for RIVA or its other systems; buyers request a consultation.1,3

Company, leadership, and revenue

ARxIUM has offices in Buffalo Grove, Illinois and Winnipeg, Manitoba. Nhat H. Ngo is chief executive.5,6

It does not publish revenue. GetLatka estimates about 14.1 million dollars with 128 employees in December 2025, so we use an estimated 15 million to 30 million dollars.7

Competitive landscape

Which of these companies scores best, and who is each one built for?Hover over or tap a logo for details.
Top rated, for smaller operationsTop rated, for large enterprisesLower score, for smaller operationsLower score, for large enterprisesNot yet reviewed45678910Review Score← Smaller operationsLarge enterprises →Who it's built for6.46.16.76.7
ARxIUM and its competitors
CompanyProductPricing modelDeployment footprintWhere ARxIUM wins or loses
ARxIUMRIVA IV robot plus packagers, cabinets, and inventory software3Not published; consultation1More than 19 million RIVA doses4IV robot plus pharmacy automation; consultation pricing; private
EQUASHIELD ProAutomated hazardous drug compounder using closed transfer devices8Not published; quote8Equashield sells on five continents9EQUASHIELD Pro wins on closed transfer protection from start to finish. ARxIUM wins on one vendor for IV robots and wider pharmacy automation.
KIRO OncologyTwo-arm hazardous drug compounder with gravimetric checks10Not published; quote10Part of the inclusiv IV compounding portfolio15KIRO Oncology wins on gravimetric checks and self-cleaning. ARxIUM wins on one vendor for IV robots and wider pharmacy automation.
OmnicellIVX Station robot inside the IV Compounding Service13Not published; service model13Hospitals, clinics, and care settings12Omnicell wins on a managed IV compounding service. ARxIUM wins on one vendor for IV robots and wider pharmacy automation.
Loccioni APOTECAchemoAPOTECAchemo IV chemotherapy compounding robot14Not published14User community across the US, Europe, the Gulf, and Asia14Loccioni wins on an established chemo compounding user community. ARxIUM wins on one vendor for IV robots and wider pharmacy automation.

Limits

No published prices.1

Revenue is not published.7

RIVA is one product in a broad line, so buyers should check its roadmap and support directly.1

What customers say

Where it helps

An IV compounding robot plus packaging, dispensing, and inventory systems from one vendor.1,3

Where it falls short

Pricing only through a consultation.1

Leadership

ARxIUM does not publish leadership photos. Nhat H. Ngo is chief executive officer.6

    Sources